Research News

Older patients should take PPIs to cut risk of bleed from aspirin, study says

BMJ 2017; 357 doi: https://doi.org/10.1136/bmj.j2865 (Published 14 June 2017) Cite this as: BMJ 2017;357:j2865
  1. Susan Mayor
  1. London

Elderly people who take long term daily aspirin have a higher than expected risk of disabling or fatal upper gastrointestinal bleeding, a major UK study has found.1 The researchers recommend prescribing proton pump inhibitors (PPIs) to prevent bleeds in older patients undergoing aspirin based antiplatelet treatment.

An estimated 40-66% of people aged over 75 in Europe and the US currently take daily aspirin or other antiplatelet drugs, often for secondary prevention of vascular disease. But guidelines recommending this treatment are based on trials carried out in younger people.

Peter Rothwell, from the Centre for Prevention of Stroke and Dementia …

View Full Text

Sign in

Log in through your institution

Free trial

Register for a free trial to thebmj.com to receive unlimited access to all content on thebmj.com for 14 days.
Sign up for a free trial

Subscribe